TRI TrivarX Limited
Healthcare · Health Information Services
· website
$0.01
52wk 0.01 – 0.04
Overall
35.7
Value
72.7
Growth
0.0
Health
69.2
Quality
24.2
Momentum
0.8
Dividend
—
Price
About TrivarX Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | -9.1% |
| 1 month | -33.3% |
| 3 months | -50.0% |
| 6 months | -41.2% |
| 1 year | -9.1% |
| 3 years | -50.0% |
Risk
| Volatility (1y ann.) | 195.9% |
| Beta vs ASX 200 | 1.93 |
| Sharpe (1y) | 0.59 |
| VaR 95% (1-day) | -10.7% |
| Max drawdown (1y) | -71.0% |
| Off 1-year high | -67.7% |
Technicals
| RSI(14) | 40 |
| vs 50DMA | -27.8% |
| vs 200DMA | -48.8% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
72.7
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
0
Growth
0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
24.2
Return on equity
0
Return on assets
0
Operating margin
100
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
0.8
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
4
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$11.54M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.96
Dividend yield
—
Payout ratio
0.0%
Beta
0.83
EV / EBITDA
-2.75
Price / Book
0.50
ROE
-61.2%
Operating margin
315,936.1%
Net margin
0.0%
Total cash
$2.44M
Total debt
$128,136
Current ratio
5.26
Debt / Equity
0.01
Free cash flow
$502,021
Avg volume
627,449
Latest annual results
(FY ending 30 Jun 2024)
- Revenue—
- Gross profit—
- Operating income-$2.31M
- Net income-$1.24M
- Diluted EPS-0.00
- Free cash flow-$3.98M
- Net debt-$832.20K